Vipergen Establishes Research Partnership with Aligos Therapeutics Focused on DNA Encoded Library-Based Drug Discovery for Viral Infections and Liver Diseases
November 23, 2021 at 07:00 am EST
Vipergen announced the signing of a multi-target drug discovery agreement with Aligos Therapeutics, Inc. Under the terms of the agreement, Vipergen will apply its high-fidelity DEL technology platforms to identify novel small-molecule compounds that bind to selected Aligos protein targets. Aligos will select hits for development into novel therapeutics for viral and liver diseases. Aligos will retain exclusive rights to globally commercialize any products resulting from the collaboration.